Journey Medical Ownership
| DERM Stock | USD 5.44 0.28 5.43% |
Shares in Circulation | First Issued 2014-12-31 | Previous Quarter 20 M | Current Value 20.5 M | Avarage Shares Outstanding 28.1 M | Quarterly Volatility 14.4 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Journey |
Journey Stock Ownership Analysis
About 30.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.92. Journey Medical Corp had not issued any dividends in recent years. Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 90 people. To learn more about Journey Medical Corp call the company at 480 434 6670 or check out https://journeymedicalcorp.com.Besides selling stocks to institutional investors, Journey Medical also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Journey Medical's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Journey Medical's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Journey Medical Quarterly Liabilities And Stockholders Equity |
|
Journey Medical Insider Trades History
About 30.0% of Journey Medical Corp are currently held by insiders. Unlike Journey Medical's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Journey Medical's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Journey Medical's insider trades
Journey Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Journey Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Journey Medical Corp backward and forwards among themselves. Journey Medical's institutional investor refers to the entity that pools money to purchase Journey Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Atria Investments Llc | 2024-09-30 | 44.4 K | Gladstone Institutional Advisory Llc | 2024-09-30 | 33.5 K | State Street Corp | 2024-09-30 | 25.6 K | Walleye Trading Advisors, Llc | 2024-09-30 | 23.1 K | Brighton Jones Llc | 2024-09-30 | 23 K | Perkins Capital Management Inc | 2024-09-30 | 22 K | Northern Trust Corp | 2024-09-30 | 17.7 K | Titleist Asset Management, Llc | 2024-09-30 | 14.2 K | Creative Planning Inc | 2024-09-30 | 11.8 K | Vanguard Group Inc | 2024-09-30 | 325.2 K | Cambridge Invest Research Advisors, Inc. | 2024-09-30 | 314.4 K |
Journey Medical Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Journey Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Journey Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Journey Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Journey Medical Outstanding Bonds
Journey Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Journey Medical Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Journey bonds can be classified according to their maturity, which is the date when Journey Medical Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Journey Medical Corporate Filings
13A | 29th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 13th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F4 | 1st of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share 2.921 | Quarterly Revenue Growth (0.58) | Return On Assets (0.17) | Return On Equity (1.30) |
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.